摘要
目的探讨静脉溶栓治疗缺血性脑血管病临床疗效。方法选取我科室2017年12月至2018年12月收治疗的30例缺血性脑血管病患者为研究对象,利用病例尾号单双数法将其分为两组,对照组患者15例,观察组患者15例,对照组进行常规治疗方案,观察组进行静脉溶栓治疗方案。结果对比两组患者溶栓后神经功能缺损程度及日常生活活动能力,对照两组患者溶栓后NIHSS评分,观察组为(8.56±2.35)分,对照组为(16.34±3.65)分;Bartender Index评分,观察组为(76.45±1.85)分,对照组为(39.23±0.73)分,比较差异具有统计学意义(P<0.05),差异显著。对比两组住院治疗期间并发症发生率,观察组为26.66%,低于对照组的66.66%,比较差异具有统计学意义(P<0.05)。结论静脉溶栓治疗缺血性脑血管病安全可靠,临床疗效较好,应用价值较高,值得推广应用。
Objective To explore clinical effect of intravenous thrombolysis in treatment of ischemic cerebrovascular disease.Methods We chose 30 cases of ischemic cerebrovascular disease patients admitted to our department from December 2017 to December 2018 as research objects,divided them into two groups with odd and even number method of case tail number,15 cases in control group,15 cases in observation group.Control group was treated with routine treatment,and observation group with intravenous thrombolysis.Results Compared neurological deficit degree and activities of daily living after thrombolysis between two groups of patients.NIHSS scores after thrombolysis were(8.56±2.35)points in observation group and(16.34±3.65)points in control group;Bartender Index scores of observation group was(76.45±1.85)points,and that of control group was(39.23±0.73)points,difference was statistically significant(P<0.05).Complication incidence during hospitalization was 26.66%in observation group,which was lower than 66.66%in control group.Difference was statistically significant(P<0.05).Conclusion Intravenous thrombolysis is safe and reliable in treatment of ischemic cerebrovascular disease,with good clinical effect and high application value,which is worthy of promotion and application.
作者
孙巳茵
SUN Si-yin(Jilin Central Hospital,Jilin,Jilin,132011)
出处
《智慧健康》
2020年第30期44-45,共2页
Smart Healthcare
关键词
静脉溶栓
缺血性脑血管病
临床疗效
Intravenous thrombolysis
Ischemic cerebrovascular disease
Clinical effect
